-
2024-04-30 00:44
Offer price of HK$34.00in cash per share is final and represents approximately 60.83% premium to undisturbed 60-trading day average closing price of HK$21.14 per share.€1.7 billion take-private transaction values 100% of L'Occitane International S.A. at €6.0 billion on an equity
-
2024-04-27 00:46
CASTRES, France, April 26, 2024 /PRNewswire/ -- PierreFabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSA™ (vibegron under the internatio
-
2024-04-26 15:00
-
2024-04-25 23:47
-
2024-04-25 22:12
-
2024-04-25 18:20
-
2024-04-25 10:00
-
2024-04-24 17:00
-
2024-04-24 00:18
-
2024-04-23 14:51